In a previous study, the authors reported that oncolytic virotherapy overcomes systemic tumour resistance to immune checkpoint blockade, due to the virus-induced inflammatory response which coincided with distant tumour infiltration of tumour-specific CD4+ and CD8+ T cells36. This evidence concerns the gene CD4 and neoplasm.